Impact BioMedical (IBO) Income Statement (2022 - 2026)
Income Statement report data from Jun 30, 2022 to Mar 31, 2026 for Impact BioMedical (IBO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||
Total Revenue | 10K (0.00%) | 10K (-50.00%) | 20K (+100.00%) | 10K | - | - | - | - | - | - | - | - | - | - | 50K |
Operating Expenses | |||||||||||||||
Research And Development | 50K (-54.55%) | 110K (+120.00%) | 50K (-37.50%) | 80K (-20.00%) | 100K | -110.00K | 80K (-33.33%) | 120K (-33.33%) | 180K (-79.55%) | 880K (+144.44%) | 360K (+33.33%) | 270K (+50.00%) | 180K (-45.45%) | 330K (+57.14%) | 210K |
Selling General And Administrative | 1.62M (+1250.00%) | 120K (-53.85%) | 260K (+4.00%) | 250K (0.00%) | 250K (-13.79%) | 290K (+123.08%) | 130K (-7.14%) | 140K (-6.67%) | 150K (+15.38%) | 130K (+30.00%) | 100K (+150.00%) | 40K (0.00%) | 40K (-55.56%) | 90K (+50.00%) | 60K |
Operating Expenses | 1.67M | -430.00K | 310K (-3.13%) | 320K (-68.32%) | 1.01M (-96.15%) | 26M (+2221.24%) | 1.13M (+79.37%) | 630K (-18.18%) | 770K (-32.46%) | 1.14M (+5.56%) | 1.08M (+6.93%) | 1.01M (+26.25%) | 800K (-10.11%) | 890K (+11.25%) | 800K |
Depreciation And Amortization | 280K (-3.45%) | 290K (0.00%) | 290K (0.00%) | 290K (+3.57%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K (0.00%) | 280K |
Operating Income | |||||||||||||||
Operating Income | -2.29M (+95.73%) | -1.17M (+23.16%) | -950.00K (-17.39%) | -1.15M (+13.86%) | -1.01M (-96.15%) | -26.23M (+2221.24%) | -1.13M (+79.37%) | -630.00K (-18.18%) | -770.00K (-32.46%) | -1.14M (+5.56%) | -1.08M (+6.93%) | -1.01M (+26.25%) | -800.00K (-10.11%) | -890.00K (+18.67%) | -750.00K |
Ebit | -2.29M (+95.73%) | -1.17M (+23.16%) | -950.00K (-17.39%) | -1.15M (+13.86%) | -1.01M (-96.15%) | -26.23M (+2221.24%) | -1.13M (+79.37%) | -630.00K (-18.18%) | -770.00K (-32.46%) | -1.14M (+5.56%) | -1.08M (+6.93%) | -1.01M (+26.25%) | -800.00K (-10.11%) | -890.00K (+18.67%) | -750.00K |
EBITDA | -2.00M (+127.27%) | -880.00K (+33.33%) | -660.00K (-23.26%) | -860.00K (+17.81%) | -730.00K (-97.19%) | -25.95M (+2952.94%) | -850.00K (+142.86%) | -350.00K (-28.57%) | -490.00K (-43.02%) | -860.00K (+7.50%) | -800.00K (+9.59%) | -730.00K (+40.38%) | -520.00K (-14.75%) | -610.00K (+29.79%) | -470.00K |
Other Income / Expenses | |||||||||||||||
Interest Income | 10K | - | - | - | - | -10.00K | - | - | - | - | - | - | - | - | 90K |
Interest Expense | - | - | 260K (0.00%) | 260K (-3.70%) | 270K (0.00%) | 270K (-12.90%) | 310K (+19.23%) | 260K (+13.04%) | 230K (+76.92%) | 130K (+30.00%) | 100K (-16.67%) | 120K (+20.00%) | 100K (+11.11%) | 90K (-35.71%) | 140K |
Net Interest Income | 10K | - | -260.00K (0.00%) | -260.00K (-3.70%) | -270.00K (-3.57%) | -280.00K (-6.67%) | -300.00K (+15.38%) | -260.00K (+13.04%) | -230.00K (+91.67%) | -120.00K (+20.00%) | -100.00K (-9.09%) | -110.00K (+10.00%) | -100.00K (+11.11%) | -90.00K (+80.00%) | -50.00K |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | 50K | - | - |
Net Income | |||||||||||||||
Income Before Tax | -2.28M | 2.66M | -1.47M (-89.76%) | -14.35M (+1021.09%) | -1.28M (-95.28%) | -27.10M | 4.24M | -880.00K (-12.00%) | -1.00M (-20.63%) | -1.26M (+6.78%) | -1.18M (+5.36%) | -1.12M (+31.76%) | -850.00K (-13.27%) | -980.00K (+22.50%) | -800.00K |
Income Tax Expense | - | -2.58M | - | - | - | 30K | - | - | - | - | - | - | - | 1.26M | - |
Net Income From Continuing Operations | -2.29M | 5.25M | -1.47M (-89.76%) | -14.35M (+1029.92%) | -1.27M (-95.31%) | -27.10M | 4.25M | -890.00K (-7.29%) | -960.00K (-19.33%) | -1.19M (+0.85%) | -1.18M (+5.36%) | -1.12M (+31.76%) | -850.00K (-62.05%) | -2.24M (+180.00%) | -800.00K |
Net Income | -2.29M | 5.25M | -1.47M (-89.76%) | -14.35M (+1029.92%) | -1.27M (-95.31%) | -27.10M | 4.25M | -890.00K (-7.29%) | -960.00K (-19.33%) | -1.19M (+0.85%) | -1.18M (+5.36%) | -1.12M (+31.76%) | -850.00K (-62.05%) | -2.24M (+180.00%) | -800.00K |